Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27.7M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
12.1M
-
Shares change
-
-2.29M
-
Total reported value, excl. options
-
$88M
-
Value change
-
-$14.2M
-
Number of buys
-
17
-
Number of sells
-
-35
-
Price
-
$7.29
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q2 2021
60 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q2 2021.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.1M shares
of 27.7M outstanding shares and own 43.62% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4.08M shares), Sonic Fund II, L.P. (2.43M shares), Avoro Capital Advisors LLC (1.67M shares), 683 Capital Management, LLC (1.11M shares), Solas Capital Management, LLC (868K shares), DG Capital Management, LLC (589K shares), MILLENNIUM MANAGEMENT LLC (405K shares), HARBERT FUND ADVISORS, INC. (121K shares), Russell Investments Group, Ltd. (113K shares), and Ergoteles LLC (92.3K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.